Adult T leukemia cells produce a lymphokine that augments interleukin 2 receptor expression. NLM AIDSLINE Important note: Information in this article was accurate in 1989. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Adult T leukemia cells produce a lymphokine that augments interleukin 2 receptor expression.

J Mol Cell Immunol. 1985;2(1):17-26. Unique Identifier : AIDSLINE MED/89322686
Teshigawara K; Maeda M; Nishino K; Nikaido T; Uchiyama T; Tsudo M; Wano Y; Yodoi J; Institute for Immunology, Faculty of Medicine, Kyoto University,; Japan.


Abstract: Human T-cell leukemia virus (HTLV)-infected cell lines derived from adult T-cell leukemia (ATL) express constitutively the receptor for Interleukin-2 (IL-2-R) and the associated antigen (Tac antigen). In contrast, the same antigen is transiently expressed by normal T-cells only after immune stimulation. Recently, it was reported that the constitutively expressed Tac antigen on ATL cells and cell lines was not down-regulated or modulated by anti-Tac antibody. Since the antigen was modulated on normal mitogen- or alloantigen-stimulated T-cells, we postulated that the regulation of IL-2-R may be abnormal on ATL cells; the synthesis of IL-2-R is continuously stimulated in these cells. A unique HTLV/ATLV(-) cell line (YT) derived from a child with acute lymphoblastic leukemia was found to express low levels of Tac antigen that could be enhanced by various stimuli, including conditioned medium (CM) derived from normal lymphocytes, but not by lectins (PHA, Con A). Of particular interest, the exposure of YT cells to CM from ATL cell lines with helper phenotype revealed the presence of factor(s) (ATL-derived factor, ADF) that augmented the synthesis and expression of IL-2-R/Tac antigen on YT cells and promoted YT cell growth. CM from HTLV(-) leukemia cell lines lacked both IL-2-R augmenting activity and a growth promoting activity. Immunoaffinity-purified IL-2 and recombinant gamma interferon also lacked IL-2-R augmenting activity. Moreover, the physicochemical analysis with Fast protein liquid chromatography (FPLC) revealed that ADF was quite different in pI point from the IL-2-R augmenting activity in CM from normal lymphocytes. These results suggested that ADF is a unique product of HTLV(+) cells. The possible relationship between ADF production, HTLV infection, and the abnormal expression of IL-2-R is suggested, and these abnormalities may be advantageous for the leukemogenesis and abnormal growth of ATL.
Keywords: Adolescence Antigens, Neoplasm/BIOSYNTHESIS Culture Media/PHARMACOLOGY Gene Expression Regulation/DRUG EFFECTS Human HTLV-I/*PHYSIOLOGY Killer Cells, Natural/DRUG EFFECTS/*METABOLISM Leukemia-Lymphoma, T-Cell, Acute, HTLV-I-Associated/*METABOLISM/ PATHOLOGY Leukemia, Lymphocytic, Acute/*METABOLISM/PATHOLOGY Lymphokines/PHARMACOLOGY/*SECRETION Male Neoplasm Proteins/*BIOSYNTHESIS Receptors, Interleukin-2/*BIOSYNTHESIS Stimulation, Chemical T-Lymphocytes/METABOLISM/*SECRETION T-Lymphocytes, Helper-Inducer/SECRETION Tumor Cells, Cultured/METABOLISM/SECRETION JOURNAL ARTICLE

KWDadolescenceantigens,neoplasm/biosynthesisculturemedia/pharmacologygeneexpressionregulation/drugeffectshumanhtlv-i/KWDphysiologykillercells,natural/drugeffects/KWDmetabolismleukemia-lymphoma,t-cell,acute,htlv-i-associated/KWDmetabolism/pathologyleukemia,lymphocytic,acute/KWDmetabolism/pathologylymphokines/pharmacology/KWDsecretionmaleneoplasmproteins/KWDbiosynthesisreceptors,interleukin-2/KWDbiosynthesisstimulation,chemicalt-lymphocytes/metabolism/KWDsecretiont-lymphocytes,helper-inducer/secretiontumorcells,cultured/metabolism/secretionjournalarticle
891130
M89B0557


Copyright © 1989 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1989. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1989. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .